NCT06815692 is a clinical trial of Psychoeducation in Concussion, Mild, sponsored by Rune Skovgaard Rasmussen.

Who is sponsoring NCT06815692?

NCT06815692 is sponsored by Rune Skovgaard Rasmussen.

What drugs are being tested in NCT06815692?

Interventions in NCT06815692: Psychoeducation, Physiotherapy, Treatment of tinnitus and increased sound sensitivity, Vision training and examination, Sleep guidance and education, Mindfulness with a cognitive therapeutic approach, Employment-oriented intervention, Energy management and graded exercise, Neuropsychological counseling.

What condition does NCT06815692 study?

NCT06815692 studies Concussion, Mild.

Is NCT06815692 still recruiting?

NCT06815692 is currently not yet recruiting. Last updated 12 August 2025.

Last reviewed 2025-08-12 · How we verify

NCT06815692

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interdisciplinary Interventions After mTBI

Not yet recruiting Last updated 12 August 2025

What this trial tests

trial testing Psychoeducation in Concussion, Mild in 140 participants. Not yet recruiting.

Timeline

1 January 2026

Primary endpoint
31 July 2030

31 December 2030

Quick facts

Lead sponsor	Rune Skovgaard Rasmussen
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	140
Start date	1 January 2026
Primary completion	31 July 2030
Estimated completion	31 December 2030

Drugs / interventions tested

Psychoeducation
Physiotherapy — full drug profile →
Treatment of tinnitus and increased sound sensitivity
Vision training and examination
Sleep guidance and education
Mindfulness with a cognitive therapeutic approach
Employment-oriented intervention
Energy management and graded exercise
Neuropsychological counseling

Conditions studied

Concussion, Mild — all drugs for Concussion, Mild →

Sponsor

Rune Skovgaard Rasmussen — full company profile →

Who can join

18 and older, any sex, with Concussion, Mild. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to investigate the impact of interdisciplinary and individually tailored programs for mTBI (concussion) on quality of life and work capacity, both at the conclusion of the program and after 1 and 3 years. The investigators also want to examine whether early intervention is significant by comparing individuals who enter the program between 1 and 3 months post-concussion with those who only start the program more than 9 months post-concussion. Such a study has not been conducted before and can provide valuable insights into long-term effects and the importance of early intervention

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Psychoeducation

Trials testing the same drug.

NCT07227987 — Cognitive Rehabilitation for Treatment of Anger in Veterans With TBI and PTSD · NA · not yet recruiting
NCT06755827 — Pilot Testing a Novel Approach to Pediatric Obesity Treatment · Phase 1, PHASE2 · recruiting
NCT07129369 — Effects of a Peer-facilitated, Acceptance-based Self-learning for Illness Management (PASIM) Program · NA · not yet recruiting
NCT06972368 — Home-Based tDCS for Depression in BPD · NA · recruiting
NCT07130838 — The MB-EAT Smart Teen Study · NA · not yet recruiting

Other recruiting trials for Concussion, Mild

Currently open trials in the same condition.

NCT06739785 — Turkish Translation of SportsConcussion Assesment Tool 6 · active not recruiting
NCT06559865 — Impact of a Paced Breathing Exercise Intervention on Autonomic Nervous System Function After Pediatric Concussion · NA · recruiting
NCT06105892 — Eye Recovery Automation for Post Injury Dysfunction (iRAPID) · NA · recruiting
NCT05857761 — GAIN Symptoms: Post-traumatic Headache · NA · active not recruiting

Other Rune Skovgaard Rasmussen trials

Trials by the same sponsor.

NCT07512323 — Effect of Testosterone on Elderly Frail Men With Testosterone Deficiency · Phase 2 · not yet recruiting
NCT06161129 — Filter Lenses for the Prevention of Migraine Attacks · NA · not yet recruiting
NCT07135245 — Improved Treatment and Monitoring of Alzheimer's Disease · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06815692 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rune Skovgaard Rasmussen
Last refreshed: 12 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06815692.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing